Genomind 360
Learning Center

Healthcare providers

Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy and Tolerability in Children and Adolescents

Event Card for Grand Rounds Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy and Tolerability in Children and Adolescents

Genomind and guest speaker, Dr. Jeffrey R. Strawn, MD, FAACAP, present Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy and Tolerability in Children and Adolescents. Dr. Strawn, an Associate Professor of the Department of Pediatrics at the University of Cincinnati, is a psychiatrist specializing in the neurophysiology, neurochemistry and neuroanatomy of anxiety disorders in children and adolescents. Dr. Strawn’s research has highlighted antidepressant use in pediatric patients with anxiety disorders and has also focused on examining the class-specific side effects of these agents. Dr. Strawn has extensive expertise in the conduct of clinical trials in youth with anxiety disorders and speaks extensively on mood disorders in youth. Dr. Strawn discusses using pharmacogenetics to improve antidepressant efficacy and tolerability in children and adolescents in a 45 minute presentation, then concludes with a Q&A session.

 

 

Filmed December 3rd, 2020

Deliver targeted and personalized care with Genomind.

Register with Genomind to use our precision tools and services and help your patients get better.

Continued education to evolve your practice.

Free educational content and resources direct from the Genomind team.

This field is for validation purposes and should be left unchanged.